Skip to main content

Advertisement

Log in

Closing the loop on the bone-resorbing osteoclast

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

A new study shows in mice that tumor necrosis factor (TNF) superfamily member 11 (TNFSF11, also known as RANKL), which stimulates osteoclasts to remove bone, binds to the G-protein-coupled receptor LGR4 to prevent excessive bone removal. In mouse models of osteoporosis, a recombinant LGR4 ectodomain reduces bone loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: The osteoclast negative-feedback loop.

References

  1. Häusler, K.D. et al. J. Bone Miner. Res. 19, 1873–1881 (2004).

    Article  Google Scholar 

  2. Luo, J. et al. Nat. Med 22, 539–546 (2016).

    Article  CAS  Google Scholar 

  3. Luo, J. et al. Development 136, 2747–2756 (2009).

    Article  CAS  Google Scholar 

  4. Sun, L. et al. Cell 125, 247–260 (2006).

    Article  CAS  Google Scholar 

  5. Abe, E. et al. Cell 115, 151–162 (2003).

    Article  CAS  Google Scholar 

  6. Ferlin, A., Pepe, A., Facciolli, A., Gianesello, L. & Foresta, C. Bone 46, 504–513 (2010).

    Article  CAS  Google Scholar 

  7. Yi, H., Wang, J., Kavallaris, M. & Yingzi-Wang, J. Blood 122, abstr. 887 (2013).

  8. Hur, E.M. & Zhou, F.Q. Nat. Rev. Neurosci. 11, 539–551 (2010).

    Article  CAS  Google Scholar 

  9. Li, Z., Zhang, W. & Mulholland, M.W. Front. Endocrinol. (Lausanne) 6, 131 (2015).

    PubMed Central  Google Scholar 

  10. Wu, C. et al. Nat. Commun. 5, 3149 (2014).

    Article  Google Scholar 

  11. Krausova, M. & Korinek, V. Cell. Signal. 26, 570–579 (2014).

    Article  CAS  Google Scholar 

  12. Du, B. et al. J. Biol. Chem. 288, 15131–15141 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mone Zaidi.

Ethics declarations

Competing interests

Mone Zaidi has consulted and/or consults for Merck, Novartis, Roche, Alexion, Gershon Lehman Group and Guidepoint on issues related to osteoporosis and its treatment. A patent relating to the effects of follicle-stimulating hormone on bone has been granted, and any proceeds to the Icahn School of Medicine at Mount Sinai from licensing or royalty will be shared with Dr. Zaidi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zaidi, M., Iqbal, J. Closing the loop on the bone-resorbing osteoclast. Nat Med 22, 460–461 (2016). https://doi.org/10.1038/nm.4104

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.4104

  • Springer Nature America, Inc.

This article is cited by

Navigation